Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Trinity Biotech (TRIB) Receivables Refunds (2016 - 2025)

Trinity Biotech's Receivables Refunds history spans 17 years, with the latest figure at $456000.0 for Q4 2025.

  • On a quarterly basis, Receivables Refunds fell 11.97% to $456000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $456000.0, a 11.97% decrease, with the full-year FY2025 number at $456000.0, down 11.97% from a year prior.
  • Receivables Refunds hit $456000.0 in Q4 2025 for Trinity Biotech, up from $431000.0 in the prior quarter.
  • Over the last five years, Receivables Refunds for TRIB hit a ceiling of $2.9 million in Q1 2021 and a floor of $226000.0 in Q3 2024.
  • Historically, Receivables Refunds has averaged $1.4 million across 5 years, with a median of $1.7 million in 2022.
  • Biggest five-year swings in Receivables Refunds: surged 83.72% in 2021 and later crashed 89.29% in 2024.
  • Tracing TRIB's Receivables Refunds over 5 years: stood at $1.5 million in 2021, then rose by 19.17% to $1.8 million in 2022, then fell by 17.34% to $1.5 million in 2023, then plummeted by 65.83% to $518000.0 in 2024, then dropped by 11.97% to $456000.0 in 2025.
  • Business Quant data shows Receivables Refunds for TRIB at $456000.0 in Q4 2025, $431000.0 in Q2 2025, and $518000.0 in Q4 2024.